Gatifloxacin :

Composition Ph. Ref. Strength
Benzalkonium Chloride IP 0.3%w/v
(as preservative) IP 0.01%w/v
Sterile aqueous vehicle q.s

Ofloxacin :

Composition Ph. Ref. Strength
Ofloxacin : IP 0.3%w/v
Dexamethasone Sodium Phosphate IP
Eq. to Dexamethasone Phosphate 0.05%w/v
Hydroxy Propyl methyl cellulose IP 0.025%w/v
Benzalkonium Chloride solution IP 0.01%w/v
(as preservative)
Sterile aqueous base q.s

Carboxymethyl cellulose sodium

Composition Ph. Ref. Strength
Carboxymethyl cellulose sodium IP 1.0%w/v
Stablised Oxychloro Complex 0.0075%w/v
(as preservative)
Water for Injection IP q.s

Carboxymethyl cellulose sodium

Composition Ph. Ref. Strength
Carboxymethyl cellulose sodium IP 0.5%w/v
Stabilized Oxychloro Complex
( as preservative)
In a Sterile aqueous base q.s

Carboxymethyl cellulose sodium

Composition Ph. Ref. Strength
Sodium Perborate BP 0.005%w/v
Sterile aqueous base q.s

Moxifloxacin Hydrochloride

Composition Ph. Ref. Strength
Eq. to Moxifloxacin 0.5%w/v
Ketorolac Tromethamine IP 0.5%w/v
Isotonic aqueous vehicle q.s

Timolol Maleate

Composition Ph. Ref. Strength
Timolol Maleate IP
Eqv. To Timolol 0.5%w/v
Benalkonium Chloride Solution IP 0.02%v/v
(as preservative)
Sterile aqueous vehicle q.s

Tropicamide

Composition Ph. Ref. Strength
Tropicamide IP 0.5%w/v
Chlorbutol IP 0.5%w/v
(as preservative)
Isotonic Aqueous Base q.s

Moxifloxacin Hydrochloride

Composition Ph. Ref. Strength
Moxifloxacin Hydrochloride BP
Eq. to Moxifloxacin 0.5%w/v
Prednisolone acetate IP 1.0%w/v
Benzalkonium chloride solution IP 0.02%w/v
(as preservative)
Sterile aqueous base q.s

Gatifloxacin

Composition Ph. Ref. Strength
Gatifloxacin IP 0.30%w/v
Prednisolone Acetate IP 1.0%w/v
Benzalkonium Chloride Solution IP 0.006%w/v
(as preservative)
In sterile aqueous base q.s

Each ml contains:

Composition Ph. Ref. Strength
Each ml contains:
B Fluorometholone USP 1mg
Benzalkonium Chloride IP 0.04mg
Purified Water IP q.s

Tropicamide

Composition Ph. Ref. Strength
Tropicamide IP 1.0%w/v
Phenylmercuric Nitrate IP 0.001%w/v
(as preservative)
Sterile Aqueous vehicle q.s

Tropicamide

Composition Ph. Ref. Strength
Tropicamide IP 0.8%w/v
Phenylephrine hydrochloride IP 5.0%w/v
Benzalkonium chloride solution IP 0.02%v/v
(as preservative)
Sterile aqueous base q.s

Ketorolac Tromethamine

Composition Ph. Ref. Strength
Ketorolac Tromethamine IP 0.5%w/v
Dexamethasone Sodium Phosphate IP 0.01%w/v
Hydroxy Propyl methyl cellulose IP 0.025%w/v
Benzalkonium Chloride solution IP 0.02%v/v
(as preservative)
Sterile aqueous base q.s

Phenylephrine Hydrochloride

Composition Ph. Ref. Strength
Phenylephrine Hydrochloride IP 0.12%w/v
Naphazoline Hydrochloride USP 0.05%w/v
Chlorpheniramine Maleate IP 0.1%w/v
Menthol IP 0.005%w/v
Camphor IP 0.01%w/v
Benzalkonium Chloride Solution IP 0.01%w/v
(as preservative)
In sterile aqueous base q.s

Each ml contains:

Composition Ph. Ref. Strength
Polymyxin B Sulphate BP 5000IU
Chloramphenicol IP 10mg
Dexamethasone Sodium Phosphate IP 1mg
Phenyl Mercuric Nitrate IP 0.001%w/v
(as preservatives)
Sterile aqueous base q.s

Proparacaine Hydrochloride

Composition Ph. Ref. Strength
Proparacaine Hydrochloride USP 0.5%w/v
Chlorbutol IP 0.5%w/v
(as preservative)
Sterile Aqueous base q.s

Moxifloxacin Hydrochloride

Composition Ph. Ref. Strength
Moxifloxacin Hydrochloride IP
Eq. to Moxifloxacin 0.5%w/v
Loteprednol Etabonate 0.5%w/v
Benzalkonium Chloride Solution IP 0.01%v/v
(as Preservative)
Sterile Aqueous vehicle q.s

Clotrimazole

Composition Ph. Ref. Strength
Clotrimazole IP 1%w/v
Beclomethasone Dipropionate IP 0.025%w/v
Ofloxacin IP 0.3%w/v
Lignocaine Hydrochloride Glycerine & Propylene Glycol Base IP 2%w/v
IP q.s

Naphazoline Hydrochloride

Composition Ph. Ref. Strength
Naphazoline Hydrochloride USP 0.05%w/v
Sodium Carboxy methyl cellulose IP 0.5%w/v
Phenylephrine Hydrochloride IP 0.012%w/v
Menthol IP 0.005%w/v
Camphor IP 0.01%w/v
Stabilized Oxychloro Complex 0.005%w/v
( as preservative)
Water for Injection IP q.s

Olopatadine Hydrochloride

Composition Ph. Ref. Strength
Eq. to Olopatadine 0.1%w/v
Benalkonium chloride Solution IP 0.01%w/v
(as preservative)
Sterile aqueous vehicle q.s

Chloramphenicol

Composition Ph. Ref. Strength
Chloramphenicol IP 1.0%w/v
Betametasone Sodium Phosphate IP 0.1%w/v
Benzalkonium Chloride Solution? IP 0.02%w/v
(as Preservative)
Sterile buffered Aqueous Base q.s

Potassium Iodide

Composition Ph. Ref. Strength
Potassium Iodide IP 3.3%w/v
Calcium Chloride (anhydrous) IP 1.0%w/v
Sodium Chloride IP 0.83%w/v
Methyl hydroxyl benzoate IP 0.023%w/v
Propyl hydroxyl benzoate IP 0.011%w/v
(as preservatives)
Sterile aqueous base q.s

Ketorolac Tromethamine?

Composition Ph. Ref. Strength
Ketorolac Tromethamine? IP 0.5%w/v
?Chlorpheniramine Maleate IP 0.02%w/v
?Phenylephrine Hydrochloride IP 0.012%w/v
?Hydroxy Propyl Methyl Cellulose IP 0.25%w/v
Sterile aqueous base q.s

Phenylephrine Hydrochloride

Composition Ph. Ref. Strength
Phenylephrine Hydrochloride IP 0.12%w/v
Naphazoline Hydrochloride USP 0.05%w/v
Menthol IP 0.005%w/v
Camphor IP 0.01%w/v
Phenylmercuric Nitrate IP 0.02%w/v
(as preservative)
In sterile aqueous base q.s

Chloramphenicol

Composition Ph. Ref. Strength
Chloramphenicol IP 5%w/v
Beclomethasone Dipropionate IP 0.025%w/v
Clotrimazole IP 1%w/v
Lignocaine Hydrochloride Glycerine & Propylene Glycol Base IP 2%w/v
IP q.s

Sodium Chloride

Composition Ph. Ref. Strength
Sodium Chloride IP 0.65%w/v
In purified water made isotonic and buffered.
Added Benzalkonium chloride solution
eq to Benzalkonium chloride IP
(as preservative) 0.01%w/v

Tobramycin Sulphate

Composition Ph. Ref. Strength
Tobramycin Sulphate IP
Eq. to Tobramycin 0.3%w/v
Phenyl Meruric Nitrate IP 0.002%w/v
(as preservatives)
Sterile aqueous base q.s

Moxifloxacin Hydrochloride

Composition Ph. Ref. Strength
Moxifloxacin Hydrochloride IP
Eq. to Moxifloxacin 0.5%w/v
Aqueous vehicle q.s

Ofloxacin

Composition Ph. Ref. Strength
Ofloxacin IP 0.03%w/v
Hydroxy Propyl Methyl Cellulose IP 0.25%w/v
Benzalkonium Chloride Solution IP 0.02%w/v
(As preservative)
Water for injection IP q.s

Each ml contains:

Composition Ph. Ref. Strength
Polyvinyl Alcohol USP 14mg
Povidone IP 6mg
Chlorbutanol IP 5mg
Flurbiprofen Sodium IP 0.03%w/v

Hydroxy Propyl Methyl Cellulose

Composition Ph. Ref. Strength
Hydroxy Propyl Methyl Cellulose IP 0.25%w/v
Phenyl Mercuric Nitrate IP 0.001%w/v
(Preservative)
Sterile aqueous vehicle q.s

Chlorpheniramine Maleate

Composition Ph. Ref. Strength
Chlorpheniramine Maleate IP 0.2%w/v
Naphazoline Hydrochloride USP 0.056%w/v
Phenylepherine Hydrochloride IP 0.12%w/v
Methyl-Para Hydroxy Benzoate IP 0.1%w/v
In sterile isotonic aqueous vehicle

Sulphacetamide Sodium

Composition Ph. Ref. Strength
Sulphacetamide Sodium IP 20%w/v
Methyl Cellulose IP 0.2%w/v
Phenyl mercuric Nitrate IP 0.02%w/v
In a sterile aqueous base q.s

Sulphacetamide Sodium

Composition Ph. Ref. Strength
Sulphacetamide Sodium IP 15.0%w/v
Sodium Chloride IP 0.9%w/v
Boric Acid IP 2%w/v
Zinc Sulphate IP 0.1%w/v
Chlorpheniramine Maleate IP 0.01%w/v
In a sterile aqueous base q.s

Hydroxy Proply Methyl Cellulose

Composition Ph. Ref. Strength
Hydroxy Proply Methyl Cellulose IP 2.0%w/v
Sodium Chloride IP 0.49%w/v
Potassium Chloride IP 0.075%w/v
Calcium Chloride IP 0.048%w/v
Magnesium Chloride IP 0.03%w/v
Borax IP 0.19%w/v
Boric acid IP 0.19%w/v

Naphazoline Hydrochloride

Composition Ph. Ref. Strength
Naphazoline Hydrochloride IP 0.01%w/v
Boric Acid IP 1.10%w/v
Borax IP 0.20%w/v
Benzalkonium Chloride?(As Preservative) IP 0.01%w/v
Glycerol IP 1.0%w/v
Sterile Aqueous Base q.s

Tobramycin Sulphate

Composition Ph. Ref. Strength
Tobramycin Sulphate IP
Eq. to Tobramycin 0.3%w/v
Flurometholone IP 0.1%w/v
Sterile aqueous base q.s

Naphazoline hydrochloride

Composition Ph. Ref. Strength
Naphazoline hydrochloride BP 0.05%w/v
Sodium Chloride IP 0.05%w/v
Boric Acid IP 1.25%w/v
Zinc Sulphate IP 0.12%w/v
Chlorpheniramine Maleate IP 0.01%w/v
In a sterile aqueous base q.s

Naphazoline Hydrochloride

Composition Ph. Ref. Strength
Naphazoline Hydrochloride USP 0.056%w/v
Chlorpheniramine Maleate IP 0.01%w/v
Zinc Sulphate IP 0.12%w/v
Boric Acid IP 1.25%w/v
Sodium chloride IP 0.05%w/v
Chlorbutol(as preservatives) IP 0.5%w/v
Benzalkonium Chloride Solution IP 0.005%w/v
(as preservative)
In sterile aqueous base q.s

Cholramphenicol

Composition Ph. Ref. Strength
Cholramphenicol IP 0.5%w/v
Phenyl Mercuric Nitrate IP 0.001%w/v
In sterile aqueous base q.s

Olopatadine Hydrochloride Ophthalmic solution

Composition Ph. Ref. Strength
Olopatadine Hydrochloride Ophthalmic solution IP
Olopatadine Hydrochloride
Eq. to Olopatadine 0.2%w/v
Benalkonium chloride Solution 0.01%v/v
(as preservative)
Sterile aqueous vehicle q.s